Metformin to Prevent Metabolic Complications in Glucocorticoid Excess
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if a treatment with metformin compared to placebo
reduces metabolic side-effects in patients with glucocorticoid treatment over three months
time.